PAHO Does Not Recommend Taking Products that Contain Chlorine Dioxide, Sodium Chlorite, Sodium Hypochlorite, or Derivatives, 16 July 2020
Washington, D.C.; PAHO; 2020-07-16. (PAHO/IMS/PHE/COVID-19/20-0040).
em Inglês
| PAHO-IRIS
| ID: phr-52515
Biblioteca responsável:
US1.1
ABSTRACT
PAHO does not recommend oral or parenteral use of chlorine dioxide or sodium chlorite-based products for patients with suspected or diagnosed COVID-19 or for anyone else. There is no evidence of their effectiveness and the ingestion or inhalation of such products could cause serious adverse effects.
Texto completo:
Disponível
Coleções:
Bases de dados de organismos internacionais
Base de dados:
PAHO-IRIS
Assunto principal:
Coronavirus
/
Dióxido de Cloro
/
Pandemias
/
COVID-19
Idioma:
Inglês
Ano de publicação:
2020
